You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bromodomain

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Childhood, Lymphoma, Brain Tumor, Pediatric Trial in Canada, United States (BMS-986158, BMS-986378)

Recruiting
  • Solid Tumor, Childhood
  • +2 more
  • Boston, Massachusetts
  • +5 more
Dec 27, 2022

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • Boston, Massachusetts
    Dana-Farber - Harvard Cancer Center LAO
Sep 17, 2022

AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)

Terminated
Has Results
  • AML Including AML de Novo and AML Secondary to MDS
  • DLBCL
  • Birabresib Dose 20 mg
  • (no location specified)
Aug 23, 2022

Advanced Hepatocellular Carcinoma Trial in La Jolla (SF1126, Nivolumab)

Terminated
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
May 11, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

Suspended
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Boston, Massachusetts
  • +2 more
Oct 5, 2022

Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +7 more
  • Atlanta, Georgia
  • +2 more
Nov 3, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +2 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Oct 25, 2023

Hematopoietic and Lymphoid System Tumor, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial (BET

Not yet recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +5 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Apr 6, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

NUT Midline Carcinoma, Triple Negative Breast Cancer, NSCLC With Rearranged ALK Gene/Fusion Protein or KRAS Mutation Trial

Completed
Has Results
  • NUT Midline Carcinoma
  • +5 more
  • (no location specified)
Jan 7, 2021

Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • Bethesda, Maryland
  • +4 more
Aug 16, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

MPNST, NF1, Sarcoma Trial in United States (Selumetinib)

Not yet recruiting
  • MPNST
  • +2 more
  • Birmingham, Alabama
  • +13 more
Jun 29, 2022

Glioblastoma Multiforme Trial (Birabresib)

Terminated
Has Results
  • Glioblastoma Multiforme
  • (no location specified)
Jan 7, 2021

NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC), NSCLC (NSCLC) Trial (Birabresib)

Terminated
Has Results
  • NUT Midline Carcinoma (NMC)
  • +3 more
  • (no location specified)
Jan 7, 2021

Metastatic NUT Carcinoma, Unresectable NUT Carcinoma Trial (Cisplatin, Etoposide, Etoposide Phosphate)

Withdrawn
  • Metastatic NUT Carcinoma
  • Unresectable NUT Carcinoma
  • (no location specified)
Sep 25, 2020

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Trial in Houston (Azacitidine, BRD4

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 19, 2020

Pulmonary Arterial Hypertension Trial in Calgary, Quebec City (Apabetalone)

Completed
  • Pulmonary Arterial Hypertension
  • Calgary, Alberta, Canada
  • +1 more
Apr 22, 2022

Solid Tumors, Adult Trial in Denver, Lake City, Nashville (JAB-8263)

Recruiting
  • Solid Tumors, Adult
  • Denver, Colorado
  • +2 more
Mar 11, 2022

Multiple Myeloma Trial in Australia, United Kingdom, United States (RO6870810, daratumumab)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +11 more
Feb 6, 2020

NSCLC, SCLC, CRPC Trial in Tianjin (JAB-8263)

Recruiting
  • NSCLC
  • +7 more
  • Tianjin, Tianjin, China
    Tianjin
Mar 11, 2022

Acute Myeloid Leukemia Trial (ABBV-787)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 29, 2023

Diabetes, Type 2, Coronary Artery Disease Trial in Worldwide (Apabetalone, Placebo, Atorvastatin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Coronary Artery Disease
  • Bahía Blanca, Argentina
  • +213 more
Jul 23, 2021

Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 Tablets
  • TQB3617 Capsules
  • Guangzhou, Guangdong, China
  • +19 more
Nov 7, 2023